Royalty Pharma Plc (RPRX) — Cash Flow Quality Index
Royalty Pharma Plc (RPRX) has a Cash Flow Quality Index of 2.58x as of March 2026. Operating cash flow of $760.54 Million exceeds net income of $294.69 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Royalty Pharma Plc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Royalty Pharma Plc Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Royalty Pharma Plc across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Royalty Pharma Plc (RPRX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Royalty Pharma Plc (2017–2025)
Year-by-year earnings quality comparison for Royalty Pharma Plc. For live market cap and the full company financial profile, see market cap of Royalty Pharma Plc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.88x | $2.49 Billion | $1.32 Billion | ▼ -9.6% |
| 2024 | 2.08x | $2.77 Billion | $1.33 Billion | ▲ +18.4% |
| 2023 | 1.76x | $2.99 Billion | $1.70 Billion | ▼ -81.1% |
| 2022 | 9.32x | $2.14 Billion | $230.06 Million | ▲ +473.3% |
| 2021 | 1.63x | $2.02 Billion | $1.24 Billion | ▲ +36.0% |
| 2020 | 1.20x | $2.03 Billion | $1.70 Billion | ▲ +76.5% |
| 2019 | 0.68x | $1.67 Billion | $2.46 Billion | ▼ -36.5% |
| 2018 | 1.07x | $1.62 Billion | $1.52 Billion | ▲ +1.0% |
| 2017 | 1.06x | $1.42 Billion | $1.34 Billion | — |